Earnings Per Share - Narrative (Details) - USD ($) |
1 Months Ended | 3 Months Ended | 9 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 02, 2022 |
Oct. 30, 2022 |
Oct. 31, 2021 |
Oct. 30, 2022 |
Oct. 31, 2021 |
Mar. 23, 2022 |
Oct. 01, 2021 |
Sep. 30, 2021 |
Dec. 01, 2020 |
Nov. 30, 2020 |
Jan. 31, 2019 |
|
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||||||||||
| Anti-dilutive stock options (in shares) | 50,100 | 48,000 | |||||||||
| Aggregate amount authorized for stock repurchase (up to) | $ 1,000,000,000 | $ 641,200,000 | $ 141,200,000 | $ 500,000,000 | $ 263,600,000 | $ 500,000,000 | |||||
| Remaining authorized repurchase amount | $ 812,500,000 | $ 812,500,000 | |||||||||
| Repurchase of common stock (in shares) | 1,200,000 | 1,400,000 | |||||||||
| Repurchase of common stock | $ 16,992,000 | $ 236,423,000 | $ 374,976,000 | $ 491,336,000 | |||||||
| Subsequent Event | |||||||||||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||||||||||
| Repurchase of common stock (in shares) | 9,200 | ||||||||||
| Repurchase of common stock | $ 3,400,000 | ||||||||||